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CLINICAL AND FINANCIAL CONSEQUENCES OF 

SETTING UP AN ASTHMA CLINIC AT ST LUKE'S HOSPITAL 

M. J. Ebejer, A. Galea Baron, R. Ellul-Micallef, F. F. Fenech 
ABSTRACT 
The effects of setting up an asthma clinic were assessed in an audit study. A 
comparison was made between the quality and quantity of medication used by 
patients before and after attending the asthma clinic. The number and severity of 
exacerbations during a six month period before and a six month period after 
attending were also assessed. The cost of treatment before and after was also 
calculated. In 14% of patients, occupational factors, drugs or underlying lung 
disease were significant contributors to asthma. The number of acute episodes of 
severe asthma were reduced from 98 to 47, with hospital admissions falling from 26 
to 1. Pulmonary function (%FEV.) improved in the group as a whole with the 
number of patients having their best FEV above 80% improving from 44 to 71. In 
spite of the expense of high cost drugs and the running costs of the clinic there were 
substantial savings largely from the reduced number of hospital admissions. The 
calculated annual cost fell from Lm 22,769 to Lm 10,654. 
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Introducton 
Asthma is common, causes significant morbidity 
and is potentially fatal.1.2 The prevalence and. 
mortality of asthma are increasing in several 
countries3,4 and the impression of most clinicians 
in Malta is that the same applies to our local 
population. It is probable that specialist clinics 
may achieve a higher standard of care which 
could reverse this trend.5 Asthmatics admitted to 
hospital in a ward specialising in respiratory 
medicine receive better care than those on a 
general medical wad ..6,7 Direct admission to a 
specialist respiratory medicine unit has also been 
shown to reduce mortality by about half when 
compared to routine admission to general 
medical wards via the emergency department. 8 It 
is hoped that specialist clinics might deliver 
better care while at the same time limit the ever 
increasing costs. 
In August 1991, the Department of Medicine at 
St Luke's Hospital set up an asthma clinic with 
two main purposes in mind. The first was to 
improve patient well-being on the assumption 
that asthmatics were not getting optimal care in 
general medical clinics. The second aim was to 
optimise medication in such a way as to obtain 
maximum benefit from recently introduced. 
potent but expensive drugs. and reduce 
prescriptions of less effective medication. The 
purpose of this audit, was to try and quantify how 
far the aims have been achieved and to assess the 
financial implications. 
Comprehensive guidelines on the management of 
asthma have now been issued by various medical 
associations.9 Our clinic began being run on 
similar principies. Shortcomings uncovered by 
this audit should therefore be evaluated with 
these guidelmes in mind. 
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Method 
The medical records of all patients referred to the 
asthma clinic in the first year of its operation 
were reviewed. For this purpose, a form was 
designed to record each patient's characteristics, 
clinical category of asthma, number of acute 
exacerbations, medication before and after 
attending the clinic, inhaler technique, and 
pulmonary function. 
The clinical categories of asthma were defined as 
follows: 
1. 	 Not asthma. These were the few patients 
who on assessment did not in fact have 
asthma. 
2. 	 Exercise-induced. Only those patients who 
were asymptomatic most of the time but 
developed asthma on exercise were included. 
3. 	 Occupational. Patients in whom asthma was 
unequivocally aggravated by to known 
allergens at work and whose asthma remitted 
or improved substantially when the exposure 
ceased. 
4. 	 Drug-induced. Patients in whom a drug 
known to cause asthma was temporally 
associated with symptoms and in whom 
improvement was maintained when the drug 
was withdrawn. 
5. 	 Associated with bronchopulmonary disease. 
In this category were included those patients 
whose underlying lung disease antidated 
their asthma and was clearly separable from it. 
6. 	 Associated with systemic vasculitis. 
7. 	 Atopic. Patients who were skin-test positive 
or who had seasonal conjunctivitis rhinitis 
associated with asthma. 
8. 	 Non-atopic. All patients whose asthma could 
not be placed in the above categories. 
Inhaler Technique. This was recorded only if 
there was a note in the medical records which 
allowed interpretation so as to classify the 
technique as useless, inadequate, adequate or 
excellent. 
Medication. The number of daily maintenance 
doses of each drug in each patient before and 
after attending the clinic were recorded. When 
patients first attended the clinic there were often 
important changes in drug management. 
Therefore it was decided arbitrarily to consider 
treatment as "maintenance", three months after 
attending the clinic for the first time. For 
medication used intermittently, the mean daily 
consumption was estimated where records were 
inadequate. The use of antibiotics and 
antihistamines was also recorded. The monetary 
cost and the consumption of each of the 
commonly used drugs were calculated for the 
group as a whole and a comparison made before 
and after attendance at the asthma clinic. 
Pulmonary Function. For the purposes of this 
study, only the FEY I was recorded and 
expressed as % predicted. For each patient. the 
value when first seen at the clinic and the 
subsequent best and worst values were recorded. 
Episodes of acute severe asthma. Each acute 
episode which required the attention of a doctor 
or the patient's attendance to a clinic or hospital, 
was recorded with the required therapeutic 
intervention. It was arbitrarily decided to 
compare a six month period before with a six 
month period after attending the clinic. This 
meant that some patients' records were excluded 
either because they contained inadequate 
information before attending or they had not yet 
been followed up for long enough. 
Estimating total costs. The cost of hospital care 
was calculated according to the Department of 
Health's budgeting criterion of 60 Maltese Liri 
per patient per day. The cost of all the staff 
working regularly in the clinic was taken into 
account. Their individual salaries were 
multiplied by the fraction of the time each 
devoted to the clinic. The cost of performing the 
pulmonary function test was calculated as the 
fraction of the total capital expenditure to set up 
the laboratory taking account that the time it was 
used for the clinic was 30% of the total and that 
notional depreciation was 20%. 
Results 
Patient characteristics and clinical categories 
(Figures I and 11). There were 196 patients 
referred to the asthma clinic between August 
1991 and July 1992. Ten records could not be 
traced and 21 patients did not have asthma. Of 
the remaining 165 patients, 82 were men (mean 
age 35.7 years for men, 42.2 for women). 
Inhaler Technique (Table I). All patients on 
inhalers should have had their inhaler technique 
checked regularly. Of 163 patients using 
metered dose inhalers before attending the clinic, 
only 28 had a note in their records indicating that 
their inhaler technique was checked by their 
clinicians, and of these only eight could use it 
adequately. Of 153 patients on inhalers after 
attending the asthma clinic only 50 were 
recorded as checked and of these, 39 could use 
~ , 
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FIGURE I - Age and sex distribution of patients attending asthma clinic. 
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FIGURE 11 - Clinical Categories of Asthma as defined in text. 
the inhaler at least adequately; 11 could not, and 
no decisive action was recorded as having been 
taken about this. There were no comments in 
bronchodilators before afterany case-notes about the use of spacer devices. 
salbutamol inhaler 139 151 
salbutamol rotacaps 1 2 
Number of patients before after salbutamol tablets 20 2 
using MOl 163 153 ipratropium bromide 11 2 
nebulised 82 agonists 14 6 
theophyllines 81 40 
Unrecorded 135 103 
corticosteroids 
Excellent use 0 9 beclomethasone inhaler 82 147 
Adequate 8 30 beclomethasone rotacaps 5 
Inadequate 
Useless 
11 
9 
7 
4 
oral steroids 
depo inj. steroids 
31 
3 
17 
0 
other drugs 
antibiotics 11 6 
TAB LE I - Records of patients' inhaler technique antihistamines 8 7 
before and after attending clinic. mucolytics/cough linctus 11 2 
Medication (Tables 11 and Ill). The number of cromoglycate inhaler 13 0 
patients given inhaled steroid prophylaxis 
increased from 82 to 147 and those using 
systemic corticosteroids regularly halved from 
34. The number of patients using inhaled TABLE 11 - Number of patients using the 
bronchodilators increased from 150 to only 160, maintenance medication before 
but there was an overall reduction in and after attending clinic. 
consumption. 
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FIGURE III - Cumulative frequencies of pulmonary function (FEV \ %predicted) 
stratified at 10% intervals, before and after attending the asthma clinic. 
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Pulmonary Function (Figure III and table IV). 
Every patient attending the clinic was meant to 
have pulmonary function testing on each visit. 
This failed on two occasions only and these were 
in the early days when the running of the clinic 
had not yet been taken over by the laboratory. In 
26 patients there was only one record because 
they had yet attended only once; five others 
defaulted from follow-up. In 35 patients, the 
FEV \ was measured twice. In 23 of these, it was 
above 80% predicted and remained in this range; 
one deteriorated; in 11 patients the FEV \ was 
below 80% predicted and remained the same or 
improved by their subsequent visit. The 
pulmonary function on the remaining 96 patients 
could be analysed more fully because these 
patients had had at least two follow-up visits. 
For convenience, the % predicted FEV 1 for these 
patients is shown in stratified 10% increments. 
On the first visit, there were 44 patients whose 
total daily use of each drug 
salbu tamol inhaler (puffs) 

low dose bee!omethasone (puffs) 

high dose beelomethasone (puffs) 

theophyll ines 

oral steroids 

(mg. predn isolone eq ulv.) 

daily cost in Maltese Lirj 
saibutamol inhaler (55e) 
beelomethasone low dose (6ge) 
beelomethasone high dose (900e) 
nebulised bronehodi lators 
(salb.75e, ipratr .24e) 
theophy llines (mean 2.5e) 
steroids (1 c) 
to tal dai ly cost 
belore alter 
630 469 
507 862 
6 152 
t59 6t 
222.5 70 
1.73 1.29 
1.75 2.97 
0.27 6.57 
11.47 3.50 
3.34 1.24 
0.45 0.14 
19.01 15.75 
TABLE III - The consumption and unit cost of 
maintenance medication before and 
after attending clinic 
FEV \ was above 80% predicted. This number 
increased to 71 on follow-up. Given that asthma 
exacerbations occur in almost all patients, the 
worst FEV 1 readings were also recorded. There 
were 38 patients whose readings did not drop 
below 80% predicted. There were 32 patients 
who on their first visit had pulmonary function 
below 60%. Only nine of these failed to 
improve. Of a total of 96 patients there were 29 
who during the follow-up period had 
exacerbations which dropped their FEV 1 to 
below 60%. 
first visit best worst 
>90% 33 57 22 
>80% 11 14 16 
>70% 12 9 17 
>60% 8 7 12 
>50% 12 5 14 
<49% 20 4 15 
TABLE IV - Pulmonary Function (% predicted 
FEV \) stratified at 10% intervals, 
comparing values before attending 
clinic with the subsequent best and 
worst values. 
Episodes of acute severe asthma (Table V). It 
was possible to compare a six month period 
before with a six month period after attending the 
clinic in 110 patients. There were 67 patients 
who between them had 98 exacerbations in the 
period before attending clinic, and in the period 
after, there were 33 patients who had 47 
exacerbations. There were 26 admisssions in 24 
patients before, compared with only one 
admission after. The hospital stay ranged from 1 
to 17 days (median 5; 95% confidence limits 2.93 
- 6.54). If the type of treatment and requirement 
for hospitalisation gives an indication as to the 
severity of the exacerbations then it can be 
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nebuliser therapy 15 (12) 4 (4) 
Lv. aminophylline 11 (3) 2 (2) 
prednisolone 46 (28) 40 (26) 
hospital admission 26 (24) (1) 
total: 98 (67) 47 (33) 
TABLE V - Episodes of acute, severe asthma 
grouped according to main therapeutic 
intervention comparing 6 months 
before clinic vs 6 months of follow­
up (number of patients in parentheses) 
concluded that even though the number of acute 
exacerbations was only halved, the severity was 
very much reduced during the period of follow­
up in the asthma clinic. 
Total costs (Table VI). When the costs incurred 
in running the clinic and performing pulmonary 
function were added to the costs of drugs and 
hospital admissions, and then compared with the 
costs of treating the same group of patients 
before the setting up of the asthma clinic, there 
were large savings in spite of the apparently large 
capital outlay. 
before after 
drugs 7169 5734 
hospital care * 15600 600 
staff (one weekday) 1220 
equipment & lab. ** 3100 
total: 22769 10654 
* Calculated on a mean stay of 5 days ( 95% confidence 
interval of 6,500 - 17,500 
** 20% notional depreciation. 
TABLE VI- Comparison of the annual costs 
(Maltese Liri) based on this study 
for 165 asthmatics. 
Discussion 
We identified an association with another disease 
or an unusual underlying cause for asthma in 
14% of our patients. This figure is high because 
it reflects the bias towards referring the more 
complex, the more severe or the asthmatic more 
resistant to treatment. Nonetheless, identifying 
these patients allows for a more rational approach 
to management. It may be argued that our 
categorisation of patients into various forms of 
asthma serves little clinical purpose. The main 
reason for defining the categories was to permit 
valid comparisons should we undertake more 
clinical audits at a future date. The reasons for 
the sex distribution of our asthmatics are 
unknown. The male preponderance below the 
age of 30 years may be a reflection of the well 
known fact that asthma is commoner in young 
boys. The disease tends to remit more often in 
young women. Also, more young men are 
smokers and may have more occupational 
exposure to potential allergens. Reasons why 
women seem to outnumber men beyond the age 
of 40 years may be that more men smoke and so 
are more likely to be labelled chronic obstructive 
bronchitics. Late onset asthma especially with 
rhinitis has been found more commonly in some 
populations. IO But, there may be another factor. 
The four patients we identified as having drug 
induced asthma were women (two from non­
steroidal anti-inflammatory drugs and two from 
beta-blockers). It is our clinical impression that 
the consumption of non-steroidal anti­
inflammatory drugs is higher in women of this 
age group. 
Our study has shown that in our circumstances 
specialist care for asthma reduces morbidity 
substantially while at the same time allows 
patients' pulmonary function to improve. Our 
record keeping still needs to be improved upon. 
This was reflected in the very poor recording of 
inhaler technique which is considered essential if 
for no other reason but to'emind the clinician to 
check it regularly and correct it, and if found to 
be persistently inadequate, to prescribe an 
alternative drug delivery device. The other 
defect in our care was the remarkable lack of use 
of spacer devices. These have been shown to 
improve delivery from metered dose inhalers, 
reduce oropharyngeal side effects and systemic 
absorption and allow more patients to take 
inhaled therapy where previously their poor 
technique had precluded this.ll These two points 
were corrected immediately. It would require 
another audit to quantify to what extent their use 
has been instituted and whether or nor benefits 
have resulted. 
Systemic corticosteroids are very cheap and 
extremely effective therapy for asthma if used 
judiciously. Unfortunately, their many serious 
side-effects limit their long-term use. However, 
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they are very useful in the short term to prevent 
relapse or if instituted early to abort a more 
serious attack of acute asthma. 12,13 The clinic 
managed to halve the number of patients 
previously on long-term systemic corticosteroids. 
Many patients were receiving several drugs of 
limited or dubious efficacy, such as 
antihistamines, antitussives and several 
theophylline preparations. With an improvement 
in the patients' clinical condition, the number of 
such items was greatly reduced. 
The benefits were not achieved without an initial 
increase in cost. However, we have shown that 
in the longer term, such investment in patient 
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